• Industry: Pharmaceuticals
  • Status: Current
  • Year of investment: 2017


Enaltec Labs is an integrated pharmaceutical player with capabilities in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage formulations.

The Company also leverages its API and formulation capabilities to develop a proprietary portfolio of specialty generics.

With two API manufacturing facilities, one of which is USFDA approved, the Company supplies to regulated and semi-regulated markets.

Scroll to top